Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis

Basic Research in Cardiology

Volumn 105, Issue 1, 2010, Pages 29-38

  Nagy, Nadine ^a   Melchior Becker, Ariane ^a   Fischer, Jens W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Atherosclerosis; Extracellular matrix; Small leucine rich proteoglycans; Vascular biology

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; APOLIPOPROTEIN E; BIGLYCAN; CHOLESTEROL; DECORIN; HYDRALAZINE; MESSENGER RNA; PERLECAN; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROTEOGLYCAN; TELMISARTAN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOACCUMULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; GENE EXPRESSION; LONG TERM CARE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PLEIOTROPY; PROTEIN EXPRESSION; RNA ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; PROTEOGLYCANS;

EID: 72449179872     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-009-0051-1     Document Type: Article

References (38)

1. MS Ahmed E Oie LE Vinge A Yndestad GG Andersen Y Andersson T Attramadal H Attramadal 2003 Induction of myocardial biglycan in heart failure in rats-an extracellular matrix component targeted by AT(1) receptor antagonism Cardiovasc Res 60 557 568 10.1016/j.cardiores.2003.08.017 1:CAS:528:DC%2BD3sXptlymsLY%3D 14659801 (Pubitemid 37501113)
2. L Ameye D Aria K Jepsen A Oldberg T Xu MF Young 2002 Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis FASEB J 16 673 680 10.1096/fj.01-0848com 1:CAS:528:DC%2BD38XjsVChurk%3D 11978731 (Pubitemid 34465431)
3. E Blessing M Preusch R Kranzhofer R Kinscherf N Marx ME Rosenfeld B Isermann CM Weber J Kreuzer J Grafe HA Katus F Bea 2008 Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice Atherosclerosis 199 295 303 10.1016/j.atherosclerosis.2007.10. 037 1:CAS:528:DC%2BD1cXptVWktr0%3D 18093593
4. KG Danielson H Baribault DF Holmes H Graham KE Kadler RV Iozzo 1997 Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility J Cell Biol 136 729 743 10.1083/jcb.136.3.729 1:CAS:528:DyaK2sXhtFClt70%3D 9024701 (Pubitemid 27083772)
5. C Grothusen S Bley T Selle M Luchtefeld K Grote UJ Tietge H Drexler B Schieffer 2005 Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis Atherosclerosis 182 57 69 10.1016/j.atherosclerosis.2005.01.045 1:CAS:528:DC%2BD2MXpt1equrY%3D 16115475 (Pubitemid 41188370)
6. AM Heegaard A Corsi CC Danielsen KL Nielsen HL Jorgensen M Riminucci MF Young P Bianco 2007 Biglycan deficiency causes spontaneous aortic dissection and rupture in mice Circulation 115 2731 2738 10.1161/CIRCULATIONAHA.106.653980 1:CAS:528:DC%2BD2sXlsVOnsrc%3D 17502576 (Pubitemid 46842789)
7. F Huang JC Thompson PG Wilson HH Aung JC Rutledge LR Tannock 2008 Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development J Lipid Res 49 521 530 10.1194/jlr.M700329-JLR200 1:CAS:528:DC%2BD1cXit12is7k%3D 18033753
8. RV Iozzo 1999 The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins J Biol Chem 274 18843 18846 10.1074/jbc.274.27.18843 1:CAS:528:DyaK1MXksVWmu78%3D 10383378 (Pubitemid 29314072)
9. MA Karim DD Miller MA Farrar E Eleftheriades BH Reddy CM Breland AM Samarel 1995 Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty Circulation 91 2049 2057 1:STN:280:DyaK2M3gt1yhug%3D%3D 7895364 (see comments)
10. MG Kinsella TN Wight 1988 Isolation and characterization of dermatan sulfate proteoglycans synthesized by cultured bovine aortic endothelial cells J Biol Chem 263 19222 19231 1:CAS:528:DyaL1cXmtVOjtr0%3D 3198623
11. VV Kunjathoor DS Chiu KD O'Brien RC LeBoeuf 2002 Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis Arterioscler Thromb Vasc Biol 22 462 468 10.1161/hq0302.105378 1:CAS:528:DC%2BD38XitFGgsr0%3D 11884291 (Pubitemid 34218755)
12. PJ Little N Osman KD O'Brien 2008 Hyperelongated biglycan: the surreptitious initiator of atherosclerosis Curr Opin Lipidol 19 448 454 10.1097/MOL.0b013e32830dd7c4 1:CAS:528:DC%2BD1cXhtVOitbbI 18769225
13. Y Nakashima H Fujii S Sumiyoshi TN Wight K Sueishi 2007 Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration Arterioscler Thromb Vasc Biol 27 1159 1165 10.1161/ATVBAHA.106.134080 1:CAS:528:DC%2BD2sXktFagtL4%3D 17303781 (Pubitemid 46641972)
14. AC Newby KM Southgate M Davies 1994 Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis Basic Res Cardiol 89 Suppl 1 59 70 1:CAS:528:DyaK2cXlslKgsr0%3D 7945177
15. KD O'Brien K Lewis JW Fischer P Johnson JY Hwang EA Knopp MG Kinsella PH Barrett A Chait TN Wight 2004 Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis Atherosclerosis 177 29 35 10.1016/j.atherosclerosis.2004.07.007 15488862 (Pubitemid 39361135)
16. R Ross 1999 Atherosclerosis is an inflammatory disease Am Heart J 138 S419 S420 10.1016/S0002-8703(99)70266-8 1:STN:280:DC%2BD3c%2FgslGltQ%3D%3D 10539839
17. H Sasamura R Shimizu-Hirota H Nakaya T Saruta 2001 Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats Hypertens Res 24 165 172 10.1291/hypres.24.165 1:CAS:528:DC%2BD3MXjtVOhs7s%3D 11325076 (Pubitemid 32377588)
18. L Schaefer A Babelova E Kiss HJ Hausser M Baliova M Krzyzankova G Marsche MF Young D Mihalik M Gotte E Malle RM Schaefer HJ Grone 2005 The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages J Clin Invest 115 2223 2233 10.1172/JCI23755 1:CAS:528:DC%2BD2MXntFCmtbY%3D 16025156 (Pubitemid 41134165)
19. L Schaefer KF Beck I Raslik S Walpen D Mihalik M Micegova K Macakova E Schonherr DG Seidler G Varga RM Schaefer H Kresse J Pfeilschifter 2003 Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells J Biol Chem 278 26227 26237 10.1074/jbc.M210574200 1:CAS:528:DC%2BD3sXlt1Cltbw%3D 12719420 (Pubitemid 36835392)
20. E Schönherr HT Järveläinen MG Kinsella LJ Sandell TN Wight 1993 Platelet-derived growth factor and transforming growth factor-b1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells Arterioscler. Thromb. 13 1026 1036 8318504
21. R Shimizu-Hirota H Sasamura M Mifune H Nakaya M Kuroda M Hayashi T Saruta 2001 Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors J Am Soc Nephrol 12 2609 2615 1:CAS:528:DC%2BD38XktF2l 11729229
22. K Skalen M Gustafsson EK Rydberg LM Hulten O Wiklund TL Innerarity J Boren 2002 Subendothelial retention of atherogenic lipoproteins in early atherosclerosis Nature 417 750 754 10.1038/nature00804 1:CAS:528: DC%2BD38XksVGjuro%3D 12066187 (Pubitemid 34640629)
23. HC Stary 1994 Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries Basic Res Cardiol 89 Suppl 1 17 32 7945171
24. T Takaya S Kawashima M Shinohara T Yamashita R Toh N Sasaki N Inoue K Hirata M Yokoyama 2006 Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice Atherosclerosis 186 402 410 10.1016/j.atherosclerosis.2005.08.009 1:CAS:528:DC%2BD28Xks1Wku74%3D 16157344
25. AD Theocharis NK Karamanos 2002 Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms Atherosclerosis 165 221 230 10.1016/S0021-9150(02)00231-9 1:CAS:528: DC%2BD38Xotl2msLo%3D 12417272 (Pubitemid 35333348)
26. K Tiede K Stoter C Petrik WB Chen H Ungefroren ML Kruse M Stoll T Unger JW Fischer 2003 Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro Cardiovasc Res 60 538 546 10.1016/j.cardiores.2003.08.009 1:CAS:528:DC%2BD3sXptlymsLg%3D 14659799 (Pubitemid 37501111)
27. K Tran-Lundmark PK Tran G Paulsson-Berne V Friden R Soininen K Tryggvason TN Wight MG Kinsella J Boren U Hedin 2008 Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation Circ Res 103 43 52 1:CAS:528:DC%2BD1cXnsFOmur8%3D 18596265
28. H Ungefroren NB Krull 1996 Transcriptional regulation of the human biglycan gene J Biol Chem 271 15787 15795 10.1074/jbc.271.26.15787 1:CAS:528:DyaK28XjvFWhsb4%3D 8662974 (Pubitemid 26225360)
29. NF van Det JT Tamsma J van den Born NA Verhagen LP van den Heuvel CW Lowik JH Berden JA Bruijn MR Daha FJ van der Woude 1996 Differential effects of angiotensin II and transforming growth factor beta on the production of heparan sulfate proteoglycan by mesangial cells in vitro J Am Soc Nephrol 7 1015 1023 8829116
30. SM Weis SD Zimmerman M Shah JW Covell JH Omens J Ross Jr N Dalton Y Jones CC Reed RV Iozzo AD McCulloch 2005 A role for decorin in the remodeling of myocardial infarction Matrix Biol 24 313 324 10.1016/j.matbio.2005.05.003 1:CAS:528:DC%2BD2MXlsVClu74%3D 15949932 (Pubitemid 40853880)
31. D Westermann J Mersmann A Melchior T Freudenberger C Petrik L Schaefer R Lullmann-Rauch O Lettau C Jacoby J Schrader SM Brand-Herrman MF Young HP Schultheiss B Levkau HA Baba T Unger K Zacharowski C Tschope JW Fischer 2008 Biglycan is required for adaptive remodeling after myocardial infarction Circulation 117 1269 1276 10.1161/CIRCULATIONAHA.107.714147 1:CAS:528: DC%2BD1cXislakt78%3D 18299507
32. TN Wight 1995 The extracellular matrix and atherosclerosis Curr Opin Lipidol 6 326 334 10.1097/00041433-199510000-00013 1:CAS:528:DyaK2MXnvVOmt70%3D 8520856
33. TN Wight MJ Merrilees 2004 Proteoglycans in atherosclerosis and restenosis: key roles for versican Circ Res 94 1158 1167 10.1161/01.RES. 0000126921.29919.51 1:CAS:528:DC%2BD2cXjs1ylurY%3D 15142969 (Pubitemid 38656402)
34. KJ Williams I Tabas 1995 The response-to-retention hypothesis of early atherogenesis Arterioscler Thromb Vasc Biol 15 551 561 1:STN:280: DyaK2M3mvV2qsQ%3D%3D 7749869
35. A Woods JR Couchman 1992 Heparan sulfate proteoglycans and signalling in cell adhesion Adv Exp Med Biol 313 87 96 1:CAS:528:DyaK38XmtlSlu74%3D 1442272
36. T Xu P Bianco LW Fisher G Longenecker E Smith S Goldstein J Bonadio A Boskey AM Heegaard B Sommer K Satomura P Dominguez C Zhao AB Kulkarni PG Robey MF Young 1998 Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice Nat Genet 20 78 82 10.1038/2477 1:CAS:528:DyaK1cXmtVOmur4%3D 9731537 (Pubitemid 28455451)
37. A Zernecke C Weber 2005 Inflammatory mediators in atherosclerotic vascular disease Basic Res Cardiol 100 93 101 10.1007/s00395-005-0511-6 1:CAS:528:DC%2BD2MXjtVGktbk%3D 15645164 (Pubitemid 40361602)
38. C Zhang 2008 The role of inflammatory cytokines in endothelial dysfunction Basic Res Cardiol 103 398 406 10.1007/s00395-008-0733-0 1:CAS:528:DC%2BD1cXhtVOgu7vP 18600364